Literature DB >> 6353885

Antigenic tumor cell variants obtained with mutagens.

T Boon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6353885     DOI: 10.1016/s0065-230x(08)61034-9

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  41 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.

Authors:  T Wölfel; A Van Pel; E De Plaen; C Lurquin; J L Maryanski; T Boon
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.

Authors:  T Boon; A Van Pel
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.

Authors:  P Fuschiotti; M C Fioretti; L Romani; P Puccetti
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.

Authors:  H Ikeda; N Ohta; K Furukawa; H Miyazaki; L Wang; K Kuribayashi; L J Old; H Shiku
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative.

Authors:  M Allegrucci; P Fuschiotti; P Puccetti; L Romani; M C Fioretti
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

7.  A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic.

Authors:  D S Hoon; I A Ramshaw
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Retention of immunogenicity after X-irradiation of mouse colon tumor cells expressing the transfected influenza virus hemagglutinin gene.

Authors:  T Itaya; B Hunt; P Frost
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 9.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Adoptive immunity in mice challenged with L1210/DTIC clones.

Authors:  G Canti; L Ricci; O Marelli; P Franco; A Nicolin
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.